参考文献/References:
[1] NEMETH E, GANZ T. Anemia of inflammation[J].Hematology-Oncology Clinics of North America, 2014,28(4): 671-681, vi.
[2] SASU B J, LI Hongyan, ROSE M J, et al. Serum hepcidinbut not prohepcidin may be an effective marker for anemiaof inflammation (AI)[J]. Blood Cells Molecules andDiseases, 2010, 45(3): 238-245.
[3] GANZ T, OLBINA G, GIRELLI D, et al. Immunoassayfor human serum hepcidin[J]. Blood, 2008, 112(10):4292-4297.
[4] KWON H Y, KIM B R, KIM Y W. Association ofpreoperative anemia and perioperative allogenicred blood cell transfusion with oncologic outcomesin patients with nonmetastatic colorectal cancer[J].Current Oncology, 2019, 26(3): e357-e366.
[5] 赵灵琴，张英丽，方晨燕，等．宫颈癌放化疗患者贫血及其治疗现状的调查研究[J]．中国现代医生，2019,57（16）：131-135． ZHAO Lingqin, ZHANG Yingli, FANG Chenyan,et al. Investigation on anemia and its treatmentstatus in patients with cervical cancer undergoingradiotherapy and chemotherapy [J]. Modern ChineseMedicine,2019,57(16):131-135.
[6] WANG Yong, PROBIN V, ZHOU Daohong. Cancertherapy-induced residual bone marrow injurymechanismsof induction and implication for therapy[J].Current Cancer Therapy Reviews, 2006, 2(3): 271-279.
[7] FUKUDA H, TAKEKUMA M, HIRASHIMA Y.Vitamin B12 deficiency anemia and polyneuropathydue to chronic radiation enteritis[J]. Internal Medicine ,2019, 11(18): 3695-3699.
[8] 潘湘涛，陆晔，程旭，等．癌症患者血清Hepcidin及炎症介质细胞因子表达特点及其与贫血的关系[J]. 现代检验医学杂志，2011，26（4）：22-24, 27. PAN Xiangtao,LU Ye,CHENG Xu,et al. Expressioncharacters of serum Hepcidin,inflammatory mediatorsand cytokines in patients with cancer and the relationsbetween anemia and them [J].Journal of ModernLabortory Medicine, 2011，26（4）：22-24, 27．
[9] BHAT K, SANDLER K, DUHACHEK-MUGGY S, etal. Serum erythropoietin levels, breast cancer and breastcancer-initiating cells[J]. Breast Cancer Research, 2019,21(1): 17.
[10] 陆晔，程旭，王金湖，等．IDA 患者血清铁调素、铁幼素、膜铁转运蛋白和转铁蛋白受体2 的表达特点及意义[J]．现代检验医学杂志，2013，28（3）：24-26． LU Ye, CHENG Xu, WANG Jinhu, et al. Expressionfeature and significance of Hepcidin,Hemojuvelin,Ferroportin and TFR2 in patients with irondeficiency anemia[J].Journal of Modern LabortoryMedicine,2013,28（3）：24-26.
[11] LU Ye, CHENG Xu, LI Rong, et al. The expressionand clinical significance of ferroportin and hepcidinin breast cancer patients[J]. The Journal of the KuwaitMedical Association, 2016, 48(4): 323-327.
相似文献/References:
[1]邢瑞青,王箐,邹海,等.西安地区成人贫血状况调查分析[J].现代检验医学杂志,2015,30(06):121.[doi:10.3969/j.issn.1671-7414.2015.06.037]
XING Rui-qing,WANG Jing,ZOU Hai,et al.Investigation of Anemia among Adults in Xi’an Area[J].Journal of Modern Laboratory Medicine,2015,30(02):121.[doi:10.3969/j.issn.1671-7414.2015.06.037]
[2]杨 柯a,郭晓宇b,欧剑锋a,等.外周血粒细胞CD55,CD59和FLAER检测在贫血及PNH诊断中的意义[J].现代检验医学杂志,2017,32(03):6.[doi:10.3969/j.issn.1671-7414.2017.03.002]
YANG Kea,GUO Xiao-yub,OU Jian-fenga,et al.Diagnostic Significance of Detecting Peripheral
Blood Granulocyte CD55/CD59 and FLAER in Anemia and PNH[J].Journal of Modern Laboratory Medicine,2017,32(02):6.[doi:10.3969/j.issn.1671-7414.2017.03.002]
[3]王 尉,高志琪.慢性肾病贫血患者血清NGAL水平与缺铁状态的临床相关研究[J].现代检验医学杂志,2017,32(03):119.[doi:10.3969/j.issn.1671-7414.2017.03.032]
WANG Wei,GAO Zhi-qi.Clinical Study on NGAL and Iron Status
in Patients with Chronic Renal Anemia[J].Journal of Modern Laboratory Medicine,2017,32(02):119.[doi:10.3969/j.issn.1671-7414.2017.03.032]